In vitro and in vivo antimicrobial activities were conducted to study the anticandidal activities of nanocapsules (NCs).
The NCs showed good anticandidal activities. The disruption of cell wall and cell membrane was noted via microscopy studies. The NCs changed the normal growth profile of Candida albicans. NCs reduced the colony forming unit in kidney and blood samples. Histopathological examination showed better cell structure and coordination compared with untreated mice kidney. NCs also enhanced the natural killing properties of C. albicans by epithelial cells.
Previous study revealed that lactoferrin had potent anticandidal action against C. albicans. However, encapsulated lactoferrin has never been tested for anticandidal activity in detail. In the present study, we evaluate nanocapsulated lactoferrin for anticandidal effects. To observe the anticandidal properties of encapsulated lactoferrin, various studies were conducted. Our findings showed that encapsulated lactoferrin demonstrates remarkable efficacy against C. albicans.